Are we getting closer to using methotrexate in an optimal manner?
Gespeichert in:
| Veröffentlicht in: | Journal of clinical oncology 2011-09, Vol.29 (25), p.3493-3494 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 3494 |
|---|---|
| container_issue | 25 |
| container_start_page | 3493 |
| container_title | Journal of clinical oncology |
| container_volume | 29 |
| creator | Kamen, Barton A Bertino, Joseph R Holcenberg, John S Bleyer, W Archie |
| description | |
| doi_str_mv | 10.1200/JCO.2011.37.0312 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_886917987</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>886917987</sourcerecordid><originalsourceid>FETCH-LOGICAL-c340t-7b8167da2c76d8f17dd49a60043fb1ebda63f8ad6828b848c269e726415189ad3</originalsourceid><addsrcrecordid>eNo9kE1LxDAYhIMo7rp69yS5eWrNm7RJepJl8ZOFvSh4C2n7dq30Y01S1H9vy66ehoGZYXgIuQQWA2fs5nm1iTkDiIWKmQB-ROaQchUplabHZM6U4BFo8TYjZ95_MAaJFukpmXHQwKTO5mS5dEi_kG4xhLrb0qLpPToaejr4ybcY3vvg8NsGpHVHbUf7Xahb29DWdh2623NyUtnG48VBF-T1_u5l9RitNw9Pq-U6KkTCQqRyDVKVlhdKlroCVZZJZiVjiahywLy0UlTallJznetEF1xmqLhMIAWd2VIsyPV-d-f6zwF9MG3tC2wa22E_eKO1zEBlWo1Jtk8WrvfeYWV2bnzsfgwwM3EzIzczcTNCmYnbWLk6jA95i-V_4Q-U-AV6cWfA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>886917987</pqid></control><display><type>article</type><title>Are we getting closer to using methotrexate in an optimal manner?</title><source>MEDLINE</source><source>American Society of Clinical Oncology Online Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Kamen, Barton A ; Bertino, Joseph R ; Holcenberg, John S ; Bleyer, W Archie</creator><creatorcontrib>Kamen, Barton A ; Bertino, Joseph R ; Holcenberg, John S ; Bleyer, W Archie</creatorcontrib><identifier>ISSN: 0732-183X</identifier><identifier>EISSN: 1527-7755</identifier><identifier>DOI: 10.1200/JCO.2011.37.0312</identifier><identifier>PMID: 21810689</identifier><language>eng</language><publisher>United States</publisher><subject>Antimetabolites, Antineoplastic - administration & dosage ; Humans ; Methotrexate - administration & dosage ; Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy</subject><ispartof>Journal of clinical oncology, 2011-09, Vol.29 (25), p.3493-3494</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c340t-7b8167da2c76d8f17dd49a60043fb1ebda63f8ad6828b848c269e726415189ad3</citedby><cites>FETCH-LOGICAL-c340t-7b8167da2c76d8f17dd49a60043fb1ebda63f8ad6828b848c269e726415189ad3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,3716,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21810689$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kamen, Barton A</creatorcontrib><creatorcontrib>Bertino, Joseph R</creatorcontrib><creatorcontrib>Holcenberg, John S</creatorcontrib><creatorcontrib>Bleyer, W Archie</creatorcontrib><title>Are we getting closer to using methotrexate in an optimal manner?</title><title>Journal of clinical oncology</title><addtitle>J Clin Oncol</addtitle><subject>Antimetabolites, Antineoplastic - administration & dosage</subject><subject>Humans</subject><subject>Methotrexate - administration & dosage</subject><subject>Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy</subject><issn>0732-183X</issn><issn>1527-7755</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kE1LxDAYhIMo7rp69yS5eWrNm7RJepJl8ZOFvSh4C2n7dq30Y01S1H9vy66ehoGZYXgIuQQWA2fs5nm1iTkDiIWKmQB-ROaQchUplabHZM6U4BFo8TYjZ95_MAaJFukpmXHQwKTO5mS5dEi_kG4xhLrb0qLpPToaejr4ybcY3vvg8NsGpHVHbUf7Xahb29DWdh2623NyUtnG48VBF-T1_u5l9RitNw9Pq-U6KkTCQqRyDVKVlhdKlroCVZZJZiVjiahywLy0UlTallJznetEF1xmqLhMIAWd2VIsyPV-d-f6zwF9MG3tC2wa22E_eKO1zEBlWo1Jtk8WrvfeYWV2bnzsfgwwM3EzIzczcTNCmYnbWLk6jA95i-V_4Q-U-AV6cWfA</recordid><startdate>20110901</startdate><enddate>20110901</enddate><creator>Kamen, Barton A</creator><creator>Bertino, Joseph R</creator><creator>Holcenberg, John S</creator><creator>Bleyer, W Archie</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20110901</creationdate><title>Are we getting closer to using methotrexate in an optimal manner?</title><author>Kamen, Barton A ; Bertino, Joseph R ; Holcenberg, John S ; Bleyer, W Archie</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c340t-7b8167da2c76d8f17dd49a60043fb1ebda63f8ad6828b848c269e726415189ad3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Antimetabolites, Antineoplastic - administration & dosage</topic><topic>Humans</topic><topic>Methotrexate - administration & dosage</topic><topic>Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kamen, Barton A</creatorcontrib><creatorcontrib>Bertino, Joseph R</creatorcontrib><creatorcontrib>Holcenberg, John S</creatorcontrib><creatorcontrib>Bleyer, W Archie</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of clinical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kamen, Barton A</au><au>Bertino, Joseph R</au><au>Holcenberg, John S</au><au>Bleyer, W Archie</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Are we getting closer to using methotrexate in an optimal manner?</atitle><jtitle>Journal of clinical oncology</jtitle><addtitle>J Clin Oncol</addtitle><date>2011-09-01</date><risdate>2011</risdate><volume>29</volume><issue>25</issue><spage>3493</spage><epage>3494</epage><pages>3493-3494</pages><issn>0732-183X</issn><eissn>1527-7755</eissn><cop>United States</cop><pmid>21810689</pmid><doi>10.1200/JCO.2011.37.0312</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0732-183X |
| ispartof | Journal of clinical oncology, 2011-09, Vol.29 (25), p.3493-3494 |
| issn | 0732-183X 1527-7755 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_886917987 |
| source | MEDLINE; American Society of Clinical Oncology Online Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| subjects | Antimetabolites, Antineoplastic - administration & dosage Humans Methotrexate - administration & dosage Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy |
| title | Are we getting closer to using methotrexate in an optimal manner? |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T03%3A08%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Are%20we%20getting%20closer%20to%20using%20methotrexate%20in%20an%20optimal%20manner?&rft.jtitle=Journal%20of%20clinical%20oncology&rft.au=Kamen,%20Barton%20A&rft.date=2011-09-01&rft.volume=29&rft.issue=25&rft.spage=3493&rft.epage=3494&rft.pages=3493-3494&rft.issn=0732-183X&rft.eissn=1527-7755&rft_id=info:doi/10.1200/JCO.2011.37.0312&rft_dat=%3Cproquest_cross%3E886917987%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=886917987&rft_id=info:pmid/21810689&rfr_iscdi=true |